OurBrainBank in Forbes: White House War on GBM and more
Ed Pilkington writes about his experiences and how the White House is working to improve treatment for GBM and all cancers.
Glioblastoma is too often put in the ‘too difficult’ box. Survival rates have remained virtually the same for decades. We need more research, more urgency and more attention NOW.
JUST
JUST
ADVOCATING FOR GBM
Through our patient-centred advocacy, we hope to inspire institutional, financial, medical and regulatory reform. Our GBM Bill of Rights, developed by those affected by GBM, is designed to empower people and inspire them to call for a better approach to GBM care.
Together with our allies and partners in other GBM and brain tumor organisations, we know that we are stronger together than apart. If we join forces we can ensure people with GBM have their voices heard.
Through our patient-centred advocacy, we hope to inspire institutional, financial, medical and regulatory reform. Our GBM Bill of Rights, developed by those affected by GBM, is designed to empower people and inspire them to call for a better approach to GBM care.
Together with our allies and partners in other GBM and brain tumor organisations, we know that we are stronger together than apart. If we join forces we can ensure people with GBM have their voices heard.
TARGETED CAMPAIGNS
Ed Pilkington writes about his experiences and how the White House is working to improve treatment for GBM and all cancers.
OBB founder Jessica Morris’s book is excerpted by Forbes.
Have you or a loved one received a GBM diagnosis? We want to hear about your experience.
NW Biotherapeutics, maker of DC Vax to treat glioblastoma — applied for approval in the UK.
NW Biotherapeutics, maker of DC Vax to treat glioblastoma — applied for approval in the UK.
Ed Pilkington writes about his experiences and how the White House is working to improve treatment for GBM and all cancers.
OBB founder Jessica Morris’s book is excerpted by Forbes.
Have you or a loved one received a GBM diagnosis? We want to hear about your experience.
NW Biotherapeutics, maker of DC Vax to treat glioblastoma — applied for approval in the UK.
NW Biotherapeutics, maker of DC Vax to treat glioblastoma — applied for approval in the UK.